Hindustan Bio Sciences Intrinsic Value
Hindustan Bio Sciences intrinsic value. Hindustan Bio Sciences (HINDBIO) median intrinsic value is ₹4.00 from 6 valuation models (range ₹2–₹5), vs current price ₹6.55 — -38.9% downside (Trading Above Calculated Value), margin of safety -63.7%. Analyse Hindustan Bio Sciences ownership pattern to track promoter, FII and institutional holdings.
HINDBIO Valuation Methods Summary — DCF, Graham Number & P/E
Hindustan Bio Sciences intrinsic value across 6 models vs current price ₹6.55 — upside/downside and value range per method. For current market price and key ratios, visit HINDBIO share price.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹2.40 | ₹1.92 - ₹2.88 | -63.4% | EPS: ₹0.20, Sector P/E: 12x |
| Book Value Method | asset | ₹5.00 | ₹4.50 - ₹5.50 | -23.7% | Book Value/Share: ₹5.00, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹4.00 | ₹3.60 - ₹4.40 | -38.9% | Revenue/Share: ₹5.00, P/S: 0.8x |
| PEG Ratio Method | growth | ₹3.20 | ₹2.88 - ₹3.52 | -51.1% | EPS Growth: 20.0%, Fair P/E: 16.0x |
| Growth Adjusted P/E | growth | ₹1.96 | ₹1.76 - ₹2.16 | -70.1% | Revenue Growth: 6.0%, Adj P/E: 8.2x |
| Graham Defensive Method | conservative | ₹4.74 | ₹4.27 - ₹5.21 | -27.6% | EPS: ₹0.20, BVPS: ₹5.00 |
HINDBIO Intrinsic Value vs Market Price — All Valuation Models
Hindustan Bio Sciences fair value range ₹2–₹5 vs current market price ₹6.55 across 6 valuation models. Browse HINDBIO financial statements for revenue, profit, balance sheet and cash flow data.
HINDBIO Intrinsic Value Analysis — Undervalued or Overvalued?
Hindustan Bio Sciences median intrinsic value ₹4.00, current price ₹6.55 — Trading Above Calculated Value by 38.9%, margin of safety -63.7%.
What is the intrinsic value of HINDBIO?
Based on our comprehensive analysis using 6 different valuation methods, the estimated intrinsic value of Hindustan Bio Sciences (HINDBIO) is ₹4.00 (median value). With the current market price of ₹6.55, this represents a -38.9% variance from our estimated fair value.
The valuation range spans from ₹1.96 to ₹5.00, indicating ₹1.96 - ₹5.00.
Is HINDBIO undervalued or overvalued?
Based on our multi-method analysis, Hindustan Bio Sciences (HINDBIO) appears to be trading above calculated value by approximately 38.9%.
HINDBIO Financial Health — Key Ratios vs Industry Benchmarks
Hindustan Bio Sciences financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Operating Margin | 13.0% | Industry Standard: 20%+ | Above 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.33x | Industry Standard: 1.0x+ | Below 0.5x | Measures asset utilization efficiency |
HINDBIO Cash Flow Quality — Operating & Free Cash Flow
Hindustan Bio Sciences operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2026 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |
| March 2025 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹-1 Cr | ₹-1 Cr | Negative Cash Flow | 3/10 |
| March 2023 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |
| March 2022 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |